PropertyValue
?:abstract
  • A subset of patients with Covid-19 presents with negative RT-PCR screening but suspect CT findings. Using four commercially available anti-SARS-CoV-2 IgG immuno-assays, we found this subset constituted 9.2% of all consecutively admitted outpatients with Covid-19 in our hospital. Clinical specificity for Covid-19 of some N protein-based immuno-assays was suboptimal, as positive results were observed in control patients with recent common human coronavirus, influenza B and adenovirus infections. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s15010-020-01523-3) contains supplementary material, which is available to authorized users.
?:creator
?:doi
  • 10.1007/s15010-020-01523-3
?:doi
?:journal
  • Infection
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/ef68c500cf092ec92b5a6e72c28f6531c9792b7e.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7482374.xml.json
?:pmcid
?:pmid
?:pmid
  • 32910322.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Comparison of four commercial SARS-CoV-2 IgG immuno-assays in RT-PCR negative patients with suspect CT findings
?:type
?:year
  • 2020-09-10

Metadata

Anon_0  
expand all